Pattern of calcification: intimal vs. medial, and difference below and above the knee. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD.

Size: px
Start display at page:

Download "Pattern of calcification: intimal vs. medial, and difference below and above the knee. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD."

Transcription

1 Pattern of calcification: intimal vs. medial, and difference below and above the knee Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA

2 Conflict of Interest Declaration Institution grant/research support 480 Biomedical, Abbott Vascular, Atrium, BioSensors International, Biotronik, Boston Scientific, Cordis J&J, GSK, Kona, Medtronic, MicroPort Medical, CeloNova, OrbusNeich Medical, ReCore, SINO Medical Technology, Terumo Corporation, and W.L. Gore, Spectronics, CSI, Lutonix Bard, Surmodics, Microport, Meril Life Sciences Speaking Honoraria Abbott, Cook Medical

3 Talk Outline Intimal and Medial calcification in peripheral arteries Are patterns of calcification above and below the knee different and if so how? In diabetics is there excessive calcification and what type?

4 Intimal Calcification in commonly observed in SFA-POPLITIAL ARTERIES

5 Mönckeberg s Medial Calcification in Asymptomatic Individuals Ca ++ I Ca ++ M Kolodgie F, et al. ESVB 2007:49-70

6 Histologic Sections from Patients with CLI Undergoing a Lower Limb Amputation Dorsalis pedis segment with CTO neovascularization Posterior tibial artery with atheromatous thromboemboli recanalization fragmentation of elastin layer Posterior tibial artery with circumferential medial calcification Ca Ca Soor GS, et al. Pathology 2008;40:

7 Medial and Intimal calcification of the SFA PIT Intimal Calcification Medial Calcification

8 A B C D CV LEFT SFA E A B C D E F G H I J F J I H G

9 Popliteal artery Nodular calcification Ca2+ Plaque rupture with sheet calcification and propagated thrombus

10 Medial Calcification (Mönckeberg s) in dorsalis pedis artery

11 Study of Vascular calcification in human peripheral arteries Vascular calcification was assessed with five severely calcified peripheral arteries. Type of calcification: None, Microcalcification, Fragmented calcification, Sheet calcification, Nodular calcification Intimal vs. Medial calcification Bone formation 170 histologic sections (86 sections from superficial femoral artery [SFA] and 84 sections from popliteal artery) were evaluated.

12 Vascular calcification in human peripheral arteries, from 5 asymptomatic individuals Microcalcification Fragmented calcification Sheet calcification Nodular calcification

13 The relationship between % stenosis and plaque type 100% SFA+POP lesion (532 sections from 6 legs) 100% Below the knee lesion (1270 sections from 6 legs) 90% 90% 80% 80% 70% 60% 50% 40% 30% 20% 10% 0% 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 70% 60% 50% 40% 30% 20% 10% 0% n=16 n=64 0% n=76 n=73 n=59 n=60 n=66 n=42 n=25 n=51 n=502 n=68 n=68 n=73 n=56 n=59 n=69 n=88 n=106 n= % 10-20% 20-30% 30-40% 40-50% 50-60% 60-70% 70-80% 80-90% % AIT/Fibrous PIT Fibroatheroma Fibrocalcific plaque Nodular calcification TCFA Thrombus Total occlusion Fibrocalcific and nodular predominate (Rupture + Erosion) Fibrocalcific and fibroatheroma predominate

14 The relationship between % stenosis and intimal calcification pattern by histology SFA+POP lesion (369 sections from 6 legs) Below the knee lesion (1270 sections from 6 legs) 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 100% 90% 80% 70% 60% 50% 40% 30% 20% 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 10% 0% 0-20% 20-40% 40-60% 60-80% % 0-20% 20-40% 40-60% 60-80% % 0% n=71 n=87 n=72 n=69 n=70 n=569 n=125 n=76 n=82 n= % 20-40% 40-60% 60-80% % none microcalcification Fragmented Nodular calcification sheet Microcalcification and fragmented predominate Nodular and sheet calcification predominate

15 Quadrant Calcification Grade Fanelli et al. Cardiovasc Intervent Radiol (2014) 37: Calcification in 10 asymptomatic legs. (preliminary data) AK 444 lesions BK 1126 lesions Intimal Medial 65.9% 24.4% 8.9% 0.8% 90.6% 7.2% 1.9% 0.2% Intimal 81.1% 10.0% 6.9% 0.2% Medial 98.2% 1.5% 0.3% 0%

16 Peripheral vascular disease: who gets it and why? 58 patients (33 men [57%] and 25 females [43%]), age 43 to 95 years (mean 68.7±12.5 years), who underwent a lower extremity amputation (33 [57%] below knee and the rest 25 [43%] above knee) over a 2 year period (Jan 2002 to Dec 2003). 50% had extensive non-healing ulcers and 71% had gangrene, which was more frequent in diabetics (n=34) versus non-diabetics (n=8, p=0.0032). The presence of medial calcification and concomitant atherosclerosis was observed in 168 (77%) of the 218 arterial segments with atherosclerotic plaques. However, the extent of atherosclerosis did not correlate with the extent of medial calcification. Soor GS, et al. Pathology 2008;40:

17 Diabetics have greater atherosclerosis, calcification and neovascularization than non-diabetics Characteristics Diabetic Non-diabetic P valve Number of Patients Medial calcification 40 (type II 80%) % (majority having >50% medial calcification) 28.6% P<0.001 Soor GS, et al. Pathology 2008;40:

18 Conclusion Intimal Atherosclerosis Calcification is frequently observed in both coronary and peripheral artery disease Coronary arteries do not show medial calcification but it is commonly observed in patients with peripheral vascular disease. Our data suggest atherosclerotic and medical calcification is more common above the knee. The most frequent type of calcification is fragmented but sheets of calcification is most frequent in the femoral than popliteal arteries Bone formation AK is seen in 10 to 15% of patients with peripheral vascular disease. Its significance is unknown. Medial calcification is common in peripheral arteries, especially in diabetes and CKD.

19 Funding CVPath Institute Inc. Acknowledgments CVPath Institute Sho Torii, MD Kazuyuki Yahagi, MD Hiroyoshi Mori, MD Emanuel Harari, MD Elena Ladich, MD Robert Kutz, MS Ed Acampado, DVM Youhui Liang, MD Abebe Atiso, HT Jinky Beyer Lila Adams, HT Frank D Kolodgie, PhD Liang Guo, PhD Renu Virmani, MD Washington DC My afinn@cvpath.org

20 Pattern of calcification: intimal vs. medial, and difference below and above the knee Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA

Comparison of particulate embolization in different DCB formulations. Aloke V. Finn, MD CVPath Institute Inc. Gaithersburg, MD.

Comparison of particulate embolization in different DCB formulations. Aloke V. Finn, MD CVPath Institute Inc. Gaithersburg, MD. Comparison of particulate embolization in different DCB formulations. Aloke V. Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Conflict of Interest Declaration Institution grant/research support 48

More information

Drug eluting devices: Why paclitaxel works above the knee and sirolimus below the knee, is the stent or the drug?

Drug eluting devices: Why paclitaxel works above the knee and sirolimus below the knee, is the stent or the drug? Drug eluting devices: Why paclitaxel works above the knee and sirolimus below the knee, is the stent or the drug? Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Conflict of Interest Declaration

More information

A study of downstream events of the two leading DCBs on the market. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA

A study of downstream events of the two leading DCBs on the market. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA A study of downstream events of the two leading DCBs on the market Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Disclosure Statement of Financial Interest Within the past 12 months, I or

More information

Pre-clinical comparison of drug coated balloons. Renu Virmani, MD CVPath Ins5tute Inc. Gaithersburg, MD. USA

Pre-clinical comparison of drug coated balloons. Renu Virmani, MD CVPath Ins5tute Inc. Gaithersburg, MD. USA Pre-clinical comparison of drug coated balloons Renu Virmani, MD CVPath Ins5tute Inc. Gaithersburg, MD. USA Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner

More information

How DCB drug dose effects vessel healing. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA

How DCB drug dose effects vessel healing. Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA How DCB drug dose effects vessel healing Aloke Finn, MD CVPath Institute Inc. Gaithersburg, MD. USA Disclosure Statement of Financial Interest Speaker's name : Aloke, Finn, Gaithersburg I have the following

More information

Drug Eluting Stent DES Pathology Update What we know, what we do not know

Drug Eluting Stent DES Pathology Update What we know, what we do not know Drug Eluting Stent DES Pathology Update What we know, what we do not know 13 th Summit TCT Asia 25 th April 2008 Renu Virmani, MD. CVPath Institute Inc. Gaithersburg, MD Disclosure Statement of Financial

More information

Atherectomy with thrombectomy of. Rotarex S : The Leipzig experience

Atherectomy with thrombectomy of. Rotarex S : The Leipzig experience Atherectomy with thrombectomy of femoropopliteal occlusions with Rotarex S : The Leipzig experience Dr. Bruno Freitas, Prof., MD Department of Interventional Angiology, Universität Leipzig, Germany Santa

More information

Sites of Atherosclerosis In order of Frequency

Sites of Atherosclerosis In order of Frequency Pathological Features of Peripheral Atherosclerosis: Implication for Device Development G Nakazawa Tokai Univ. Kanagawa, Japan 1 Sites of Atherosclerosis In order of Frequency carotid (3) (3) Coronary

More information

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical

More information

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005 Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque

More information

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Faculty Disclosure Thomas Zeller, MD For the 12 months preceding this presentation, I disclose the following types of

More information

The Latest Experimental Results of Endothelialization with BuMA stent. Renu Virmani, MD CVPath Institute, Inc. Gaithersburg, Maryland, USA

The Latest Experimental Results of Endothelialization with BuMA stent. Renu Virmani, MD CVPath Institute, Inc. Gaithersburg, Maryland, USA The Latest Experimental Results of Endothelialization with BuMA stent Renu Virmani, MD CVPath Institute, Inc. Gaithersburg, Maryland, USA In Stent Re -stenosis [%] Neointimal Thickness [mm] A Great Success

More information

CLI Treatment Using Long and Scoring Balloons

CLI Treatment Using Long and Scoring Balloons CLI Treatment Using Long and Scoring Balloons Robert Beasley, MD Director of Vascular and Interven3onal Radiology Mount Sinai Medical Center Miami Beach, FL Disclosures Consultant/Advisory Board: Abbott

More information

Recent Advances in Peripheral Salvage

Recent Advances in Peripheral Salvage Recent Advances in Peripheral Salvage Dr Shaiful Azmi Yahaya, MD, MMed, FNHAM, FAsCC, FAPSIC Consultant Cardiologist and Peripheral Interventionist, Institut Jantung Negara Disclosure I am proctoring for

More information

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Andrew Holden, MBChB, FRANZCR, EBIR Director of Interventional Radiology Auckland, New Zealand LINC 2017 January 25 th 2017 Disclosure

More information

Can IVUS Define Plaque Features that Impact Patient Care?

Can IVUS Define Plaque Features that Impact Patient Care? Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center

More information

Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty

Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty Poster No.: C-2067 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Scientific Exhibit Interventional

More information

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu When and how to use distal protection devices for lower extremity revascularization Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu Disclosure Peter A. Schneider Potential conflicts of interest

More information

Access strategy for chronic total occlusions (CTOs) is crucial

Access strategy for chronic total occlusions (CTOs) is crucial Learn How Access Strategy Impacts Complex CTO Crossing Arthur C. Lee, MD The Cardiac & Vascular Institute, Gainesville, Florida VASCULAR DISEASE MANAGEMENT 2018;15(3):E19-E23. Key words: chronic total

More information

The Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience

The Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience The Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany Disclosure Speaker name: Dierk Scheinert I have

More information

Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial

Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial Prof. Thomas Zeller, MD Department Angiology Clinic for Cardiology and Angiology II University Heart-Center

More information

Drug-coated balloons in BTK:

Drug-coated balloons in BTK: Drug-coated balloons in BTK: Where do we stand and what are the open questions? Dr. Marc Bosiers LINC 2019 - Leipzig My disclosures x o I do not have any potential conflicts of interest to report o I have

More information

Hydrodynamic boost: a novel re-entry technique in distal BTK vessel: when and how to do it

Hydrodynamic boost: a novel re-entry technique in distal BTK vessel: when and how to do it Hydrodynamic boost: a novel re-entry technique in distal BTK vessel: when and how to do it Roberto Ferraresi Peripheral Interventional Unit Bergamo Italy Disclosure Roberto Ferraresi, MD I have the following

More information

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,

More information

Biomechanics and Inflammation in Atherosclerotic Plaque Erosion and Plaque Rupture: Implications for Cardiovascular Events in Women

Biomechanics and Inflammation in Atherosclerotic Plaque Erosion and Plaque Rupture: Implications for Cardiovascular Events in Women Biomechanics and Inflammation in Atherosclerotic Plaque Erosion and Plaque Rupture: Implications for Cardiovascular Events in Women Ian Campbell, Emory University Jonathan D. Suever, Emory University Lucas

More information

Left main coronary artery (LMCA): The proximal segment

Left main coronary artery (LMCA): The proximal segment Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary

More information

Practical Point in Holistic Diabetic Foot Care 3 March 2016

Practical Point in Holistic Diabetic Foot Care 3 March 2016 Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai

More information

Alternative concepts for drug delivery in BTK arteries the LIMBO project

Alternative concepts for drug delivery in BTK arteries the LIMBO project Alternative concepts for drug delivery in BTK arteries the LIMBO project Dierk Scheinert, MD Division of Interventional Angiology University Hospital Leipzig, Germany 1 Disclosure Speaker s name: Dierk

More information

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI 1 Disclosures I have no financial disclosures related to this talk Objectives 1. Discuss indications for intervention

More information

The Pathology of Neoatherosclerosis in Human Coronary Implants

The Pathology of Neoatherosclerosis in Human Coronary Implants Journal of the American College of Cardiology Vol. 57, No. 11, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.011

More information

Patterns of Vessel Calcification and Clinical Relevance

Patterns of Vessel Calcification and Clinical Relevance Patterns of Vessel Calcification and Clinical Relevance Michael R. Jaff, DO Paul and Phyllis Fireman Endowed Chair in Vascular Medicine Massachusetts General Hospital Professor of Medicine Harvard Medical

More information

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have

More information

Approach to the Patient with (suspected) Arterial Insufficiency Related Ulceration

Approach to the Patient with (suspected) Arterial Insufficiency Related Ulceration Approach to the Patient with (suspected) Arterial Insufficiency Related Ulceration Elisa C. Taffe, MD, CWSP Vascular Medicine Medical Director Allegheny General Advanced Wound Healing and Lymphedema Center

More information

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC

Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,

More information

Leg arteries : MANAGEMENT and STRATEGY

Leg arteries : MANAGEMENT and STRATEGY Leg arteries : MANAGEMENT and STRATEGY Prof E. Ducasse Unit of vascular surgery BORDEAUX ESVB May 14th 2011 BARD Symposium CLI : definition Fontaine Rutherford ABI Symptoms class category Asymptomatic

More information

Assessment of Vulnerable Plaque by IVUS and VH-IVUS

Assessment of Vulnerable Plaque by IVUS and VH-IVUS Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research

More information

EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists

EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists EVALUATION OF THE VASCULAR STATUS OF DIABETIC WOUNDS Travis Littman, MD NorthWest Surgical Specialists Nothing To Disclosure DISCLOSURES I have no outside conflicts of interest, financial incentives, or

More information

Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy

Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department Careggi  University Hospital Florence - Italy Don t Use Risky and Embolizing Drug Coated Balloons Below The Knee! Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy

More information

Update on the Levant 2 Clinical Trial Programme. Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany

Update on the Levant 2 Clinical Trial Programme. Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany Update on the Levant 2 Clinical Trial Programme Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany Disclosure Speaker name: Dierk Scheinert I have the following potential conflicts of interest

More information

Do we really need a stent in long SFA lesions? No: DEB is the answer

Do we really need a stent in long SFA lesions? No: DEB is the answer Do we really need a stent in long SFA lesions? No: DEB is the answer Thomas Zeller, MD University Heart-Center Freiburg-Bad Krozingen Bad Krozingen Germany My Disclosures: Advisory Board: Medtronic-Invatec,

More information

Can We Identify Vulnerable Patients & Vulnerable Plaque?

Can We Identify Vulnerable Patients & Vulnerable Plaque? Can We Identify Vulnerable Patients & Vulnerable Plaque? We Know Enough to Treat High-Risk Lesions? Takashi Akasaka, MD, PhD Department of Cardiovascular Medicine, Japan Disclosure Statement of Financial

More information

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

Update on the OPTIMIZE BTK Trial. Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria

Update on the OPTIMIZE BTK Trial. Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria Update on the OPTIMIZE BTK Trial Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria Disclosure Speaker name: Marianne Brodmann, MD... I have the following potential conflicts

More information

Michael K. W. Lichtenberg, MD, FESC Westfälische Wilhelms-Universität Münster. Dierk Scheinert, M.D. Universitätsklinikum Leipzig AöR

Michael K. W. Lichtenberg, MD, FESC Westfälische Wilhelms-Universität Münster. Dierk Scheinert, M.D. Universitätsklinikum Leipzig AöR Michael K. W. Lichtenberg, MD, FESC Westfälische Wilhelms-Universität Münster Dierk Scheinert, M.D. Universitätsklinikum Leipzig AöR Disclosure Dierk Scheinert, MD Advisory Board /Consultant: Abbott, Biotronik,

More information

Latest Insights from the LEVANT II study and sub-group analysis

Latest Insights from the LEVANT II study and sub-group analysis Latest Insights from the LEVANT II study and sub-group analysis Prof. Dr. med. Dierk Scheinert Division of Interventional Angiology University-Hospital Leipzig, Germany Conflicts of Interest Advisory Board

More information

Copyright HMP Communications

Copyright HMP Communications Ocelot With Wildcat in a Complicated Superficial Femoral Artery Chronic Total Occlusion Soundos K. Moualla, MD, FACC, FSCAI; Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI From Phoenix Heart Center, Phoenix,

More information

Novel concept for drug delivery in infrapopliteal arteries The LIMBO trial

Novel concept for drug delivery in infrapopliteal arteries The LIMBO trial Novel concept for drug delivery in infrapopliteal arteries The LIMBO trial Prof. Dr. med. Dierk Scheinert Division of Interventional Angiology University Hospital Leipzig, Germany 1 Disclosure Advisory

More information

Now That You Have the Tools

Now That You Have the Tools blockosu@gmail.com Now That You Have the Tools Alan Jay Block, DPM, MS, FASPS, FACFAS Assistant Professor Dept Of Orthopeadics The Ohio State University Medical Board Kent State University Editor-in -Chief

More information

Thrombosis and Inflammation. What is the Next Target for New Drugs? CVPath Institute

Thrombosis and Inflammation. What is the Next Target for New Drugs? CVPath Institute Thrombosis and Inflammation in Plaque Vulnerability: What is the Next Target for New Drugs? Dr. Renu Virmani, MD CVPath Institute Gaithersburg, MD, USA Natural History of Atherosclerosis Systemic factors

More information

Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention?

Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention? Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention? Michael Wholey, MD, MBA San Antonio, TX USA 19/06/2009 at 09:35 during 4mn as a Speaker Session: Improving Femoral Artery Recanalization

More information

Device Evolution. Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance. Where Do We Stand? 4/18/2015

Device Evolution. Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance. Where Do We Stand? 4/18/2015 Disclosure Statement of Financial Interest Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement

More information

The Utility of Atherectomy and the Jetstream Atherectomy System

The Utility of Atherectomy and the Jetstream Atherectomy System The Utility of Atherectomy and the Jetstream Atherectomy System William A. Gray, MD Columbia University Medical Center 2014 Boston Scientific Corporation or its affiliates. All rights reserved. IMPORTANT

More information

6-month 0utcomes of a Novel Sirolimus Coated DCB Technology Evaluated in SFA Thomas Zeller, MD University Heart Center Freiburg-Bad Krozingen

6-month 0utcomes of a Novel Sirolimus Coated DCB Technology Evaluated in SFA Thomas Zeller, MD University Heart Center Freiburg-Bad Krozingen First Report of the SELUTION Trial: 6-month 0utcomes of a Novel Sirolimus Coated DCB Technology Evaluated in SFA Thomas Zeller, MD University Heart Center Freiburg-Bad Krozingen On behalf of the SELUTION

More information

Lutonix DCB in BTK Update on the BTK real world registry and RCT

Lutonix DCB in BTK Update on the BTK real world registry and RCT Lutonix DCB in BTK Update on the BTK real world registry and RCT Prof. Dr. med. Dierk Scheinert Department of Interventional Angiology University Hospital Leipzig Disclosures Speaker: Prof. Dr. med. Dierk

More information

Pulsar stent technology

Pulsar stent technology Pulsar stent technology Michael K. W. Lichtenberg Vascular Center Arnsberg Disclosures Speaker name: Michael Lichtenberg... I have the following potential conflicts of interest to report: X Consulting

More information

LIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37:

LIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37: LIBERTY 360 Study LIBERTY is a prospective, observational, multi-center study to evaluate procedural and long-term clinical and economic outcomes of endovascular device interventions in patients with symptomatic

More information

Peripheral artery disease (PAD) is a major cause of

Peripheral artery disease (PAD) is a major cause of Effective Debulking With the JETSTREAM System Strategies for effective treatment of PAD in the era of drug-coated balloons and contemporary stenting. BY THOMAS M. SHIMSHAK, MD, FACC, FSCAI Variable TABLE

More information

Peripheral Arterial Disease Extremity

Peripheral Arterial Disease Extremity Peripheral Arterial Disease Lower Extremity 05 Contributor Dr Steven Chong Advisors Dr Ashish Anil Dr Tay Jam Chin Introduction Risk Factors Clinical Presentation Classification History PHYSICAL examination

More information

The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA

The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA BATTLE RCT investigators: Y. Gouëffic, A. Sauguet, P. Desgranges, P. Feugier, E. Rosset, E. Ducasse,

More information

SUPERSUB Trial: 1-yr outcomes of SUPERa SUBintimal stenting in CLI Patients

SUPERSUB Trial: 1-yr outcomes of SUPERa SUBintimal stenting in CLI Patients SUPERSUB Trial: 1-yr outcomes of SUPERa SUBintimal stenting in CLI Patients Dr. L.M. Palena, MD Interventional Radiology Unit Foot & Ankle Clinic Policlinico Abano Terme (PD), ITALY Disclosure I have the

More information

Maximizing Outcomes in a complex population with Drug-coated balloon

Maximizing Outcomes in a complex population with Drug-coated balloon Maximizing Outcomes in a complex population with Drug-coated balloon March 13, 2018 Chumpol Wongwanit, MD Siriraj Hospital, Mahidol University, Bangkok, Thailand LINC Asia-Pacific 2018, Hong Kong Disclosure

More information

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything

More information

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park DCB in my practice: How the evidence influences my strategy Yang-Jin Park Associate Professor Division of Vascular Surgery, Department of Surgery Samsung Medical Center Sungkyunkwan University School of

More information

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data) Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data) (Angiolite BTK DES, IVascular) P. Goverde MD, K. Taeymans MD, K. Lauwers MD Vascular Clinic ZNA Antwerp,Belgium

More information

Chapter 43 Noninvasive Coronary Plaque Imaging

Chapter 43 Noninvasive Coronary Plaque Imaging hapter 43 Noninvasive oronary Plaque Imaging NIRUDH KOHLI The goal of coronary imaging is to define the extent of luminal narrowing as well as composition of an atherosclerotic plaque to facilitate appropriate

More information

Peripheral arterial disease for primary care Ed Aboian, MD

Peripheral arterial disease for primary care Ed Aboian, MD Peripheral arterial disease for primary care Ed Aboian, MD Division of Vascular and Endovascular Surgery Palo Alto Medical Foundation, Burlingame Ca Disclosures Nothing to disclose Clinical presentation

More information

Why and where do I use mechanical debulking for the treatment of arterial occlusions?

Why and where do I use mechanical debulking for the treatment of arterial occlusions? Why and where do I use mechanical debulking for the treatment of arterial occlusions? Prof. Thomas Zeller Department Angiology University Heart-Center Freiburg - Bad Krozingen Bad Krozingen, Germany Faculty

More information

Appropriate Device Selection for Endovascular Procedures

Appropriate Device Selection for Endovascular Procedures Appropriate Device Selection for Endovascular Procedures Thomas M. Shimshak, MD Florida Hospital Heartland Medical Center Sebring, Florida Disclosures Speaker s Bureau: Abbott Vascular Boston Scientific

More information

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee Marianne Brodmann, MD Medical University Graz Graz, Austria Critical Limb Ischemia Infrapopliteal arterial disease is a leading source

More information

Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment

Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment European Heart Journal (2015) 36, 2147 2159 doi:10.1093/eurheartj/ehv205 REVIEW Imaging Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment Fumiyuki

More information

When is below-the-ankle angioplasty indicated and how to introduce it into your practice. Roberto Ferraresi. Peripheral Interventional Unit

When is below-the-ankle angioplasty indicated and how to introduce it into your practice. Roberto Ferraresi. Peripheral Interventional Unit When is below-the-ankle angioplasty indicated and how to introduce it into your practice Roberto Ferraresi Peripheral Interventional Unit Bergamo Italy www.robertoferraresi.it Disclosure Roberto Ferraresi,

More information

In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons

In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons Ehrin J. Armstrong, MD MSc Director, Interventional Cardiology VA Eastern Colorado Healthcare System Associate Professor of Medicine

More information

Drug Elution, Data, and Decisions

Drug Elution, Data, and Decisions Drug Elution, Data, and Decisions What the data tell us about how to integrate drug-eluting technology into our daily practice. BY GARY ANSEL, MD, AND JOHN A. PHILLIPS, MD The use of drug-eluting technology

More information

New Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis

New Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis New Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis Ehrin J. Armstrong, MD MSc Director, Interventional Cardiology VA Eastern Colorado Healthcare System Associate Professor

More information

Optical Coherence Tomography for Intracoronary Imaging

Optical Coherence Tomography for Intracoronary Imaging Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

More information

There are multiple endovascular options for treatment

There are multiple endovascular options for treatment Peripheral Rotablator Atherectomy: The Below-the-Knee Approach to Address Calcium Head On Peripheral Rotablator s front-cutting, diamond-tipped burr provides stable rotation in calcified lesions. BY SONYA

More information

OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter. Patrick Muck, MD

OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter. Patrick Muck, MD OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter Patrick Muck, MD Chief, Division of Vascular Surgery Good Samaritan Hospital Cincinna

More information

Pathology of the Vulnerable Plaque

Pathology of the Vulnerable Plaque Journal of the American College of Cardiology Vol. 47, No. 8 Suppl C 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.10.065

More information

Vessel Preparation Prior to DCB and Stenting: How to Do It.

Vessel Preparation Prior to DCB and Stenting: How to Do It. Vessel Preparation Prior to DCB and Stenting: How to Do It. LINC 2018 January 30 February 2, 2018 Leipzig, Germany Brian DeRubertis, MD, FACS Associate Professor of Surgery UCLA Division of Vascular Surgery

More information

Endovascular Intervention BtK Intervention in Patients with Chronic Dialysis

Endovascular Intervention BtK Intervention in Patients with Chronic Dialysis Endovascular Intervention BtK Intervention in Patients with Chronic Dialysis GB Danzi, MD Ospedale Maggiore Policlinico Milan Italy Disease Pattern in PAD Hypercholesterolemia Age ESRD Current smoking

More information

Directional Atherectomy and Gender Outcomes in DEFINTIVE LE

Directional Atherectomy and Gender Outcomes in DEFINTIVE LE Directional Atherectomy and Gender Outcomes in DEFINTIVE LE Lawrence A. Garcia MD, on behalf of the DEFINITIVE LE Investigators Chief, Section Interventional Cardiology St. Elizabeth s Medical Center,

More information

Michael K. W. Lichtenberg MD, FESC on behalf of KANSHAS 1 investigators; Tepe G, Müller-Hülsbeck S, Deloose K, Verbist J, Goverde P, Zeller T

Michael K. W. Lichtenberg MD, FESC on behalf of KANSHAS 1 investigators; Tepe G, Müller-Hülsbeck S, Deloose K, Verbist J, Goverde P, Zeller T Interim 30-day analysis from the KANSHAS 1 study of the novel KANSHAS drug coated balloon for treatment of femoropopliteal occlusive disease; a latest first-in-human study Michael K. W. Lichtenberg MD,

More information

Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD

Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor of Vascular Surgery University of New South Wales Sydney,

More information

Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France

Forget about the angiosome theories. Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France Forget about the angiosome theories Yann Gouëffic, MD, PhD Department of vascular surgery, institut du thorax, Nantes, France Disclosure of Interest Research grants /Consulting/Honoraria for - Abbott -

More information

Lessons learnt from DES in the SFA is there any ideal concept so far?

Lessons learnt from DES in the SFA is there any ideal concept so far? Wednesday, January 25, 2017 - Time: 11:49-11:55 DEEP DIVE SESSION: Lower limb interventions (part II) Lessons learnt from DES in the SFA is there any ideal concept so far? S.Müller-Hülsbeck, MD, EBIR,

More information

Blood Vessels. Dr. Nabila Hamdi MD, PhD

Blood Vessels. Dr. Nabila Hamdi MD, PhD Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types

More information

Angiosome revascularization strategies in real world practice: how much difference does it make?

Angiosome revascularization strategies in real world practice: how much difference does it make? Angiosome revascularization strategies in real world practice: how much difference does it make? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have

More information

I am no good at debates!

I am no good at debates! Disclosure Statement of Financial Interest Imaging Strategy for Claudication: Ultrasound Alone is Not Adequate to Select Patients for Endovascular Intervention Within the past 12 months, I or my spouse/partner

More information

IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC

IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC The opinions and clinical experiences presented herein are for informational purposes only. Dr. Arko is a paid consultant for

More information

Michael K.W. Lichtenberg, MD

Michael K.W. Lichtenberg, MD Ranger All-Comer Registry Treatment of femoropopliteal atherosclerotic lesions using the Drug eluting Balloon Ranger: An All Comers Registry Michael K.W. Lichtenberg, MD Klinikum Arnsberg Arnsberg, Germany

More information

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC Plaque Characteristics in Coronary Artery Disease Chourmouzios Arampatzis MD, PhD, FESC Disclosure Statement of Financial Interest Regarding this Presentation NONE Atherosclerosis Model proposed by Stary

More information

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview Tips and Tricks for Tibial Intervention Donald L. Jacobs, MD C Rollins Hanlon Endowed Professor and Chair Chair of Surgery Saint Louis University SSM-STL Saint Louis University Hospital Disclosures Abbott

More information

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Matthew P. Namanny DO, FACOS Vascular/Endovascular Surgery Saguaro Surgical/AZ Vascular Specialist Tucson Medical Center Critical Limb

More information

Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results.

Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results. Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results. Wronski J. 1), 2) 3), Wilczynski M 1), Gembal P 1), Milik K 1), Dec St 1), Grybos

More information

Imaging Atheroma The quest for the Vulnerable Plaque

Imaging Atheroma The quest for the Vulnerable Plaque Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing

More information

Three main types of vascular calcification have been

Three main types of vascular calcification have been ATVB in Focus Vascular Calcification: Basic Mechanisms to Clinical Perspectives Series Editors: Ann Marie Schmidt and Renu Virmani Has Our Understanding of Calcification in Human Coronary Atherosclerosis

More information

Preliminary 6-month results of VMI-CFA trial

Preliminary 6-month results of VMI-CFA trial Preliminary 6-month results of VMI-CFA trial Koen Deloose, MD Head Vascular Surgery, AZ Sint Blasius, Dendermonde, Belgium Disclosure slide Speaker name: Koen Deloose, MD I have the following potential

More information

Rotarex mechanical debulking: The Leipzig experience in patients

Rotarex mechanical debulking: The Leipzig experience in patients Rotarex mechanical debulking: The Leipzig experience in 1.200+ patients Dierk Scheinert, MD Division of Interventional Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Dierk Scheinert

More information

Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease

Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease Thomas M. Shimshak, MD Heart and Vascular Center Florida Hospital Heartland Medical Center

More information